Immunoglobulins comprising predominantly a GICNAcMan3GIcNAc2 glycoform

Details for Australian Patent Application No. 2006287173 (hide)

Owner GlycoFi, Inc

Inventors Wildt, Stefan; Gerngross, Tillman U.; Li, Huijuan

Agent Spruson & Ferguson

Pub. Number AU-A-2006287173

PCT Pub. Number WO2007/028144

Priority 60/714,109 02.09.05 US; 60/714,108 02.09.05 US

Filing date 1 September 2006

Wipo publication date 8 March 2007

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

Event Publications

3 April 2008 PCT application entered the National Phase

  PCT publication WO2007/028144 Priority application(s): WO2007/028144

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006287175-Chemo-sensitivity assays using tumor cells exhibiting persistent phenotypic characteristics

2006287169-Implantable devices and methods for treating micro-architecture deterioration of bone tissue